| Unique ID issued by UMIN | UMIN000061980 |
|---|---|
| Receipt number | R000070922 |
| Scientific Title | A verification study to evaluate the safety of excessive consumption of the test food: a randomized, placebo-controlled, double-blind, parallel-group comparison study |
| Date of disclosure of the study information | 2026/06/19 |
| Last modified on | 2026/06/19 17:35:50 |
A verification study to evaluate the safety of excessive consumption of the test food
A verification study to evaluate the safety of excessive consumption of the test food
A verification study to evaluate the safety of excessive consumption of the test food: a randomized, placebo-controlled, double-blind, parallel-group comparison study
A verification study to evaluate the safety of excessive consumption of the test food
| Japan |
Healthy Japanese
| Not applicable | Adult |
Others
NO
To verify the safety of excessive consumption of the test food.
Safety
Pragmatic
Not applicable
1. Individuals who experienced adverse events
1. Individuals whose values of urinalysis and peripheral blood test are outside the reference range after intervention despite within the reference range at screening
2. Physical measurements, urine test, peripheral blood test
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
Institution is not considered as adjustment factor.
YES
Central registration
2
Educational,Counseling,Training
| Food |
Duration: 4 weeks
Test product: Food 1
Duration: 4 weeks
Test product: Food 2
| 18 | years-old | <= |
| Not applicable |
Male and Female
1. Japanese
2. Men or women
3. Adults
4. Healthy individuals
1. Individuals who are receiving treatment for or have a history of malignant tumors, heart failure, or myocardial infarction
2. Individuals who have an implanted pacemaker or implantable cardioverter defibrillator
3. Individuals who are currently undergoing treatment for any of the following chronic diseases:
cardiac arrhythmia, liver disorder, chronic kidney disease, cerebrovascular disorder, rheumatic disease, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases
4. Individuals who consume Foods for Specified Health Uses or Foods with Functional Claims
5. Individuals who are taking or using medications (including herbal medicines) or supplements
6. Individuals who regularly consume tsubo grass
7. Individuals who are allergic to medications or foods related to the test product
8. Individuals who are pregnant, lactating, or planning pregnancy during this study
9. Individuals who are deemed unsuitable for participation in this study by the principal investigator
20
| 1st name | Tsuyoshi |
| Middle name | |
| Last name | Takara |
Medical Corporation Seishinkai, Takara Clinic
Director
141-0022
9F Taisei Bldg., 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-5793-3623
t-takara@takara-clinic.com
| 1st name | Naoko |
| Middle name | |
| Last name | Suzuki |
ORTHOMEDICO Inc.
R&D Department
112-0002
2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan
03-3818-0610
nao@orthomedico.jp
ICHIMARU PHARCOS Co., Ltd.
ICHIMARU PHARCOS Co., Ltd.
Profit organization
The ethical committee of the Takara Clinic, Medical Corporation Seishinkai
9F Taisei Bldg., 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan
03-5793-3623
IRB@takara-clinic.com
NO
医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)
南町医院 (東京都)
Nerima Medical Association, Minami-machi Clinic (Tokyo, Japan)
| 2026 | Year | 06 | Month | 19 | Day |
Unpublished
Open public recruiting
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 06 | Month | 10 | Day |
| 2026 | Year | 06 | Month | 19 | Day |
| 2026 | Year | 09 | Month | 09 | Day |
| 2026 | Year | 06 | Month | 19 | Day |
| 2026 | Year | 06 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070922